Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0117630 METHODS AND DRUG COMPOSITIONS FOR TREATING LYME DISEASE
Disclosed herein are methods and drug compositions for treating Lyme disease and post-treatment Lyme disease syndrome (PTLDS) or chronic Lyme disease (CLD). In...
2019/0117629 Sustained Release Pharmaceutical Compositions and Methods of Use
Disclosed herein are methods and pharmaceutical compositions for sustained release of anticancer agents. Such pharmaceutical compositions may provide a...
2019/0117628 Ifetroban Treatment for Systemic Sclerosis
The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective...
2019/0117627 POLYMORPHIC FORMS AND PROCESS
The present invention relates to a polymorph of a compound of formula (I) ##STR00001## This polymorph is particularly suitable in treating IPF by pulmonary ...
2019/0117626 METHOD OF TREATING MULTIPLE SCLEROSIS
The invention provides a composition for oral administration that is formulated for human administration in unit dosage form and contains as its sole active...
2019/0117625 METHOD OF TREATING MULTIPLE SCLEROSIS
The invention provides a composition for oral administration that is formulated for human administration in unit dosage form and contains as its sole active...
2019/0117624 THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASES
A therapeutic agent for inflammatory bowel diseases comprising as an active ingredient a compound represented by the formula (I) wherein R represents a...
2019/0117623 ALPHA-1-ADRENERGIC RECEPTOR AGONIST THERAPY
Presented herein, inter alia, are novel methods of treating heart diseases.
2019/0117622 PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
Treatment of multiple myeloma with a combination of panobinostat and bortezomib at specified doses adjusted for safety.
2019/0117621 STABILIZED STATIN FORMULATIONS
The present invention is directed to statin formulations having improved solubility and/or stability and methods for the same.
2019/0117620 CHEMOTHERAPY IMPROVEMENTS
A method for treating or preventing cancer including administering to a person in need thereof a first composition including a platin, a taxane, or combination...
2019/0117619 USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED DISORDERS
The present invention relates to the use of cannabidiolic acid (CBDA) in the treatment of autism spectrum disorder (ASD) and ASD-associated disorders, such as...
2019/0117618 ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS
A method for providing a steady state plasma concentration of about 20-400 ng/ml of isoflavonoid compounds comprising the steps of a first rectal...
2019/0117617 COMPOUND AND METHOD FOR TREATMENT OF DISEASES AND DISORDERS
The disclosed invention generally relates to treatment and/or prevention of symptoms associated with cannabinoid responsive diseases and disorders in subjects...
2019/0117616 METHOD FOR REGULATING KDM4A, KDM4B, AND KDM4C ACTIVITY
The present invention relates to a method for inhibiting activity of a protein selected from the group consisting of KDM4A, KDM4B, and KDM4C, comprising the...
2019/0117615 TREATMENT OF CARDIAC DYSFUNCTION
A method for treatment of cardiac dysfunction comprising administering to a subject in need thereof a therapeutically effective amount of at least one of...
2019/0117614 COMBINATION OF ADRENALIN WITH AN ANTIDEPRESSANT FOR USE IN THE TREATMENT OF SHOCKS
The present invention concerns a novel combination of adrenalin with an antidepressant and its use as a pharmaceutical composition for the treatment of shocks....
2019/0117613 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are...
2019/0117612 GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT
A method of management of migraine symptom reduction and/or management and/or prophylaxis is disclosed using 3-hydroxybutyrate glycerides is disclosed.
2019/0117611 ANAPLEROTIC AGENTS FOR TREATMENT OF DISORDERS OF PROPIONATE AND LONG CHAIN FAT METABOLISM
Methods of treating propionic acidemia (PA), methylmalonic acidemia (MMA) and fatty acid oxidation disorders are described. The methods include administering...
2019/0117610 METHOD OF DIETARY TREATMENT FOR GENETIC AND EPIGENETIC DISEASES AND DISORDERS
Genetic and epigenetic diseases and disorders are treated with FDA approved dietary compositions in the form of dietary supplements and nutraceuticals. The...
2019/0117609 LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS
Provided herein is technology relating to lipid compositions containing bioactive fatty acids and particularly, but not exclusively, to compositions and...
2019/0117608 METHODS AND COMPOSITION FOR SUPPRESSION OF PATHOGENIC BACTERIAL GROWTH, FUNGAL GROWTH, OR MICROBIAL GROWTH IN...
The present disclosure relates to methods and compositions for suppressing pathogenic bacterial growth, fungal growth, or microbial growth in or on a selected...
2019/0117607 FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME
Compositions comprising fatty acid analogs are provided for treating metabolic syndrome, anemia, cancer, cardiovascular disease, diabetes, dyslipidemia,...
2019/0117606 COMPOSITIONS COMPRISING L-THEANINE, PROANTHOCYANIDIN/S AND A CATECHIN AND USES THEREOF
The present invention relates to compositions including L-theanine, proanthocyanidin(s); and a catechin selected from the group consisting of epigallocatechin...
2019/0117605 PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE
The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the...
2019/0117603 TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS
A method of treating cancer is disclosed comprising administering to a patient in need of such treatment a RXR agonist at a level below the RAR activating...
2019/0117602 PREVENTION AND REVERSAL OF INFLAMMATION INDUCED DNA DAMAGE
Methods of reducing neuronal sensitivity, thereby reducing inflammation and chronic pain, are disclosed herein. Particularly disclosed are methods of...
2019/0117601 Treatment of ADHD
A method is provided for treating a subject in need of therapy for attention deficit hyperactivity disorder (ADHD) and related CNS disorder symptoms of...
2019/0117600 HIGH CONCENTRATION MEDICANT SOLUTIONS FOR TREATING NEUROLOGICAL DISORDERS
Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may...
2019/0117599 SOLID ORAL FORMULATION OF FENRETINIDE
Amorphous solid dispersions suitable for oral delivery comprising fenretinide or an analog thereof and at least one matrix polymer, and processes for making...
2019/0117598 METHOD OF TREATING CARDIOVASCULAR EVENTS USING COLCHICINE CONCURRENTLY WITH AN ANTIPLATELET AGENT
Methods of treating and/or preventing a cardiovascular event in a patient, the method comprising orally administering a colchicine to a patient who is...
2019/0117597 ANALOGS OF CYP-EICOSANOIDS FOR USE IN TREATING OR PREVENTING A DISORDER ASSOCIATED WITH NEOVASCULARIZATION...
The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from...
2019/0117596 TY-52156 COMPOUNDS FOR THE TREATMENT OF CANCER
TY-52156 compounds for the treatment of lung cancers and cancers mediated by KRAS gene mutations and/or TGF-.beta./Smad3 signaling are described. TY-52156...
2019/0117595 METHOD FOR TREATING PLEUROPERITONEAL MEMBRANE CANCERS BY LOCALLY INJECTING DISULFIRAM PREPARATION
The present invention provides a method for treating pleuroperitoneal membrane cancers, and comprises: delivering disulfiram or a derivative thereof that is...
2019/0117594 FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE
The present Invention relates to the use of choline butyrate or butyrylcholine in food and in particular in the treatment of Intestinal disorders and in the...
2019/0117593 Paediatric Compositions for Treating Multiple Sclerosis
The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C.sub.2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a...
2019/0117592 RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND
The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least...
2019/0117591 PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not...
2019/0117590 Compositions and Methods for Treating Hyperproliferative Disorders
A method of treating a hyperproliferative disorder in a subject in need of such treatment, comprising administering to said subject, in combination, a...
2019/0117589 Substituted Hydroxystilbenes as AhR and Nrf2 modulators and their therapeutic applications
It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore,...
2019/0117588 TREATMENT OF AUTISM WITH CANNABIDIOL
The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally...
2019/0117587 SOLUBLE HONOKIOL DERIVATIVES
The invention provides a soluble honokiol detivative (such as a water soluble honokiol derivative) and its application in antagonizing glycoprotein VI receptor...
2019/0117586 METHODS OF PREVENTING OR TREATING PARKINSON'S DISEASE BY THE FARNESYLATION OF PARIS
Methods of preventing or treating Parkinson's disease in subjects are described where drugs are administered to subjects in effective amounts to cause the...
2019/0117585 A DEVICE FOR THE TRANSDERMAL DELIVERY OF BUPRENORPHINE
A device for the transdermal administration of Buprenorphine, which comprises an adhesive matrix, a backing layer and release liner, where such adhesive matrix...
2019/0117584 SYSTEMS AND METHODS OF ON-DEMAND CUSTOMIZED MEDICAMENT DOSES BY 3D PRINTING
Systems and methods of fabricating a customized dose using a medication 3D printer are provided. According to one embodiment, a system is provided that...
2019/0117583 PROCESS FOR PREPARING THERAPEUTIC NANOPARTICLES
The present disclosure generally relates to a process for preparing therapeutic nanoparticles, where the process includes combining a therapeutic agent with a...
2019/0117582 POLY(N-BUTYL CYANOACRYLATE) NANOPARTICLE WITH DUAL MODIFICATIONS, PREPARATION METHOD AND USE THEREOF
The invention relates to a poly(n-butyl cyanoacrylate) nanoparticle with dual modifications, a drug delivery system comprising the nanoparticle, and a method...
2019/0117581 DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half...
2019/0117580 Pharmaceutical Formulation Containing Gelling Agent
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.